SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001437749-23-001431
Filing Date
2023-01-20
Accepted
2023-01-20 16:15:23
Documents
1
Group Members
DRUGCRAFTERS, LPDUGABOY INVESTMENT TRUSTJAMES D. DONDERONEXPOINT CLIMATE TECH FUND

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A nreo20230119_sc13ga.htm SC 13G/A 169313
  Complete submission text file 0001437749-23-001431.txt   171177
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81821 | Film No.: 23541157
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 CRESCENT COURT SUITE 700 DALLAS TX 75201
Business Address 300 CRESCENT COURT SUITE 700 DALLAS TX 75201 214-276-6300
NexPoint Real Estate Opportunities, LLC (Filed by) CIK: 0001957368 (see all company filings)

IRS No.: 461019134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A